Spatial Relationships in the Tumor Microenvironment Demonstrate Association with Pathologic Response to Neoadjuvant Chemoimmunotherapy in Muscle-invasive Bladder Cancer
-
Published:2023-12
Issue:
Volume:
Page:
-
ISSN:0302-2838
-
Container-title:European Urology
-
language:en
-
Short-container-title:European Urology
Author:
Beckabir WolfgangORCID,
Wobker Sara E.,
Damrauer Jeffrey S.,
Midkiff Bentley,
De la Cruz Gabriela,
Makarov Vladmir,
Flick Leah,
Woodcock Mark G.,
Grivas Petros,
Bjurlin Marc A.,
Harrison Michael R.,
Vincent Benjamin G.,
Rose Tracy L.,
Gupta Shilpa,
Kim William Y.,
Milowsky Matthew I.
Reference35 articles.
1. International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial;International collaboration of Trialists;J Clin Oncol,2011
2. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer;Grossman;N Engl J Med,2003
3. Neoadjuvant gemcitabine-cisplatin plus radical cystectomy-pelvic lymph node dissection for muscle-invasive bladder cancer: a 12-year experience;Iyer;Clin Genitourin Cancer,2020
4. Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study;Balar;Lancet Oncol,2021
5. Adjuvant nivolumab versus placebo in muscle-invasive urothelial carcinoma;Bajorin;N Engl J Med,2021
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献